Introduction by the moderator - Christoph J. Zech, Basle / CH
04:00
2
Detecting NASH and grading fibrosis in subjects with NAFLD using non-invasive imaging biomarkers - Salem Alsaqal, Uppsala / SE
08:00
3
Changes in volumetric enhancing tumour burden on CT predicts survival outcomes in patients with neuroendocrine liver metastases after intraarterial treatments - Roberto Cannella, Palermo / IT
08:00
4
Gadoxetic acid-enhanced MR imaging predictors of mortality and hepatic decompensation in Chronic Liver Disease (CLD) - Lucian Beer, Vienna / AT
08:00
5
Gadoxetic acid MRI in cirrhotic patients: radiologic-pathologic correlation in nodules without arterial enhancement and hepatobiliary hypointense pattern - Gianvito Candita, Pisa / IT
08:00
6
MRI extracellular volume fraction in liver fibrosis: a comparison of different blood pool measurements with MR elastography and histology - Verena Obmann, Bern / CH
08:00
7
The role of liver vessel volume ratio in chronic liver disease - Alexander Herold, Vienna / AT
08:00
8
Progression of portal hypertension in acute cellular rejection after liver transplantation - Ji Young Choi, Seoul / KR
08:00
9
Liver MRI: assessment of liver cirrhosis severity with extracellular volume fraction - Narine Mesropyan, Bonn / DE